Print

Eye Pitch Session

Submission deadline: Jan. 31, 11:59pm ET

The Bench to Bedside (B2B) Organizing Committee is inviting submissions of great ideas for new treatments, drugs or devices to be pitched to a panel of experts during the inaugural in-person B2B Meeting, being hosted April 21 in New Orleans, La. If you have an entrepreneurial mindset and little to no experience moving an idea forward through the pipeline, this session is for you.

If your pitch is selected, you will take part in a learning session with a panel of experts where you will present your 5- to 6-minute pitch for feedback.

At the end of the pitch session the expert panel will take part in a Q&A with the audience.

Additional pitches will be available to view during the Networking Reception from 6 - 7pm on April 21.

Submit now button


Eligibility for Eye Pitch submission

Anyone with a great idea for a new treatment, drug or device in eye and vision research can submit a pitch. The organizing committee is especially interested in hearing about ideas and products in the early- to mid-development pipeline. Submitters do not need to be ARVO members, but are expected to register for the B2B Meeting and present the work if selected. Everyone can submit one idea for consideration. Five proposals will be accepted. 

Note: The B2B Meeting Committee expects that any ideas presented are already protected by appropriate patent applications. Past Eye pitch winners are ineligible to resubmit their winning proposal. Individuals who have submitted a proposal in the past but were not selected, are eligible to resubmit an updated proposal.

Key dates for 2023 B2B Meeting

Dec. 15     Eye Pitch submission site opens
Jan. 31      Eye Pitch submission deadline (11:59pm ET)
March 1   Eye Pitch acceptance and scheduling notification sent to submitter                   

Register for B2B
Secure your spot for the 2023 B2B Meeting
Eye Pitch submission form
EyePitch proposals will be accepted up to Jan. 31, 2023